Landmark HPV vaccine study shows strong immune response in chinese women and girls
NCT ID NCT03903562
First seen Apr 13, 2026 · Last updated Apr 24, 2026 · Updated 4 times
Summary
This study tested a vaccine that protects against nine types of HPV, the virus that can cause cervical cancer. About 1,990 healthy Chinese females aged 9 to 45 took part. Researchers measured the vaccine's ability to produce antibodies and checked for safety over five years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAPILLOMAVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaihua country Center for Disease Control and Prevention ( Site 0002)
Quzhou, Zhejiang, 324300, China
-
Shaoxing keqiao center for disease prevention and control ( Site 0001)
Shaoxing, Zhejiang, 312030, China
Conditions
Explore the condition pages connected to this study.